Never before has a therapy proven more beneficial for women than men in preventing heart disease — until now. A new study found that women receive a significantly greater benefit — a 70 percent reduction in heart failure and a 72 percent reduction in death — from cardiac resynchronization therapy with defibrillator than men. Reduction of heart failure in females was twice that of males — 70 percent vs. 35 percent.